BMJ:轻中度饮酒量也会增加患癌风险

2015-08-20 MedSci 译 MedSci原创

美国国家酒精滥用与酒精中毒研究所(NIAAA)定义:轻至中度的酒精摄入量为女性1杯/天,男性2杯/天。但根据发表在BMJ杂志的最新研究,即使饮酒达到如此程度仍然会增加民众患癌症的风险。既往的研究内容大多是酗酒会增加民众患某些癌症的风险,包括乳腺癌、结肠癌、肝癌和口腔癌等。但是根据哈佛大学公共卫生学院的Edward Giovannucci博士和他的同事调查发现,轻中度饮酒量也会增加民众的患癌风险。

美国国家酒精滥用与酒精中毒研究所(NIAAA)定义:轻至中度的酒精摄入量为女性1杯/天,男性2杯/天。但根据发表在BMJ杂志的最新研究,即使饮酒达到如此程度仍然会增加民众患癌症的风险。


既往的研究内容大多是酗酒会增加民众患某些癌症的风险,包括乳腺癌结肠癌、肝癌和口腔癌等。

但是根据哈佛大学公共卫生学院的Edward Giovannucci博士和他的同事调查发现,轻中度饮酒量也会增加民众的患癌风险。 且研究者认为,如今单独探究饮酒量(不探究民众的吸烟问题)对民众患癌风险影响的研究少之又少。在饮酒导致癌症的患者中,吸烟往往起协同作用,因为饮酒者往往都会吸烟。因此在探究饮酒量对民众患癌影响的研究中,吸烟是一个混杂因素。

因此Giovannucci博士和他的同事开始探究轻中度饮酒是否会导致民众增加患癌风险,并且钻研对不吸烟的饮酒者而言,饮酒如何危害其自身健康。 

研究人员对美国88084位女性和47881位男士进行了大规模的研究,研究时长达30年之久。参与人员每4年完成一份关于饮酒量的问卷调查,并积极配合随访。

轻中度饮酒的定义为:女性饮酒量为1标准杯/天或15g/天;男性为2标准杯/天或30g/天。一标准杯的定义为饮用葡萄酒118ml或啤酒355ml。同时研究人员定时评估参与者的患癌风险,包括总体的患癌风险和某些肿瘤的患癌风险(包括结肠癌、直肠癌、肝癌、乳腺癌、口腔、咽和食管癌等)。

在30年的随访过程中,被诊断为罹患癌症的女士和男士分别为19269 位和7571 位。研究人员发现,不考虑他们的吸烟史后,轻中度饮酒量的参与者总体的患癌风险并未显著增加,只是轻微影响。但是饮酒量为轻中度的女性患乳腺癌的几率明显增大,而不论其吸烟与否;对轻中度饮酒的男士而言,只有吸烟者才会明显增加其患癌风险。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1943478, encodeId=9d0819434e8b7, content=<a href='/topic/show?id=0f2122153ec' target=_blank style='color:#2F92EE;'>#中度饮酒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22153, encryptionId=0f2122153ec, topicName=中度饮酒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Thu Feb 11 16:40:00 CST 2016, time=2016-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952975, encodeId=5b7f19529e5f7, content=<a href='/topic/show?id=6d061012155a' target=_blank style='color:#2F92EE;'>#饮酒量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101215, encryptionId=6d061012155a, topicName=饮酒量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e0330, createdName=huangdf, createdTime=Sat May 21 12:40:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847702, encodeId=5e1a184e702d5, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Apr 20 10:40:00 CST 2016, time=2016-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061476, encodeId=3b7520614e6f4, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sun Sep 06 09:40:00 CST 2015, time=2015-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35968, encodeId=59283596846, content=不错。, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ab1619415, createdName=lecoo, createdTime=Sun Aug 23 00:20:00 CST 2015, time=2015-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413431, encodeId=2e6b14134317c, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sat Aug 22 10:40:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601354, encodeId=e83316013540d, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 22 10:40:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1943478, encodeId=9d0819434e8b7, content=<a href='/topic/show?id=0f2122153ec' target=_blank style='color:#2F92EE;'>#中度饮酒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22153, encryptionId=0f2122153ec, topicName=中度饮酒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Thu Feb 11 16:40:00 CST 2016, time=2016-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952975, encodeId=5b7f19529e5f7, content=<a href='/topic/show?id=6d061012155a' target=_blank style='color:#2F92EE;'>#饮酒量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101215, encryptionId=6d061012155a, topicName=饮酒量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e0330, createdName=huangdf, createdTime=Sat May 21 12:40:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847702, encodeId=5e1a184e702d5, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Apr 20 10:40:00 CST 2016, time=2016-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061476, encodeId=3b7520614e6f4, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sun Sep 06 09:40:00 CST 2015, time=2015-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35968, encodeId=59283596846, content=不错。, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ab1619415, createdName=lecoo, createdTime=Sun Aug 23 00:20:00 CST 2015, time=2015-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413431, encodeId=2e6b14134317c, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sat Aug 22 10:40:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601354, encodeId=e83316013540d, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 22 10:40:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
    2016-05-21 huangdf
  3. [GetPortalCommentsPageByObjectIdResponse(id=1943478, encodeId=9d0819434e8b7, content=<a href='/topic/show?id=0f2122153ec' target=_blank style='color:#2F92EE;'>#中度饮酒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22153, encryptionId=0f2122153ec, topicName=中度饮酒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Thu Feb 11 16:40:00 CST 2016, time=2016-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952975, encodeId=5b7f19529e5f7, content=<a href='/topic/show?id=6d061012155a' target=_blank style='color:#2F92EE;'>#饮酒量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101215, encryptionId=6d061012155a, topicName=饮酒量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e0330, createdName=huangdf, createdTime=Sat May 21 12:40:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847702, encodeId=5e1a184e702d5, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Apr 20 10:40:00 CST 2016, time=2016-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061476, encodeId=3b7520614e6f4, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sun Sep 06 09:40:00 CST 2015, time=2015-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35968, encodeId=59283596846, content=不错。, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ab1619415, createdName=lecoo, createdTime=Sun Aug 23 00:20:00 CST 2015, time=2015-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413431, encodeId=2e6b14134317c, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sat Aug 22 10:40:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601354, encodeId=e83316013540d, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 22 10:40:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
    2016-04-20 gaoxiaoe
  4. [GetPortalCommentsPageByObjectIdResponse(id=1943478, encodeId=9d0819434e8b7, content=<a href='/topic/show?id=0f2122153ec' target=_blank style='color:#2F92EE;'>#中度饮酒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22153, encryptionId=0f2122153ec, topicName=中度饮酒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Thu Feb 11 16:40:00 CST 2016, time=2016-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952975, encodeId=5b7f19529e5f7, content=<a href='/topic/show?id=6d061012155a' target=_blank style='color:#2F92EE;'>#饮酒量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101215, encryptionId=6d061012155a, topicName=饮酒量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e0330, createdName=huangdf, createdTime=Sat May 21 12:40:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847702, encodeId=5e1a184e702d5, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Apr 20 10:40:00 CST 2016, time=2016-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061476, encodeId=3b7520614e6f4, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sun Sep 06 09:40:00 CST 2015, time=2015-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35968, encodeId=59283596846, content=不错。, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ab1619415, createdName=lecoo, createdTime=Sun Aug 23 00:20:00 CST 2015, time=2015-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413431, encodeId=2e6b14134317c, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sat Aug 22 10:40:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601354, encodeId=e83316013540d, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 22 10:40:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
    2015-09-06 sjq027
  5. [GetPortalCommentsPageByObjectIdResponse(id=1943478, encodeId=9d0819434e8b7, content=<a href='/topic/show?id=0f2122153ec' target=_blank style='color:#2F92EE;'>#中度饮酒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22153, encryptionId=0f2122153ec, topicName=中度饮酒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Thu Feb 11 16:40:00 CST 2016, time=2016-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952975, encodeId=5b7f19529e5f7, content=<a href='/topic/show?id=6d061012155a' target=_blank style='color:#2F92EE;'>#饮酒量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101215, encryptionId=6d061012155a, topicName=饮酒量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e0330, createdName=huangdf, createdTime=Sat May 21 12:40:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847702, encodeId=5e1a184e702d5, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Apr 20 10:40:00 CST 2016, time=2016-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061476, encodeId=3b7520614e6f4, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sun Sep 06 09:40:00 CST 2015, time=2015-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35968, encodeId=59283596846, content=不错。, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ab1619415, createdName=lecoo, createdTime=Sun Aug 23 00:20:00 CST 2015, time=2015-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413431, encodeId=2e6b14134317c, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sat Aug 22 10:40:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601354, encodeId=e83316013540d, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 22 10:40:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
    2015-08-23 lecoo

    不错。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1943478, encodeId=9d0819434e8b7, content=<a href='/topic/show?id=0f2122153ec' target=_blank style='color:#2F92EE;'>#中度饮酒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22153, encryptionId=0f2122153ec, topicName=中度饮酒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Thu Feb 11 16:40:00 CST 2016, time=2016-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952975, encodeId=5b7f19529e5f7, content=<a href='/topic/show?id=6d061012155a' target=_blank style='color:#2F92EE;'>#饮酒量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101215, encryptionId=6d061012155a, topicName=饮酒量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e0330, createdName=huangdf, createdTime=Sat May 21 12:40:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847702, encodeId=5e1a184e702d5, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Apr 20 10:40:00 CST 2016, time=2016-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061476, encodeId=3b7520614e6f4, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sun Sep 06 09:40:00 CST 2015, time=2015-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35968, encodeId=59283596846, content=不错。, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ab1619415, createdName=lecoo, createdTime=Sun Aug 23 00:20:00 CST 2015, time=2015-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413431, encodeId=2e6b14134317c, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sat Aug 22 10:40:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601354, encodeId=e83316013540d, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 22 10:40:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1943478, encodeId=9d0819434e8b7, content=<a href='/topic/show?id=0f2122153ec' target=_blank style='color:#2F92EE;'>#中度饮酒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22153, encryptionId=0f2122153ec, topicName=中度饮酒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Thu Feb 11 16:40:00 CST 2016, time=2016-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1952975, encodeId=5b7f19529e5f7, content=<a href='/topic/show?id=6d061012155a' target=_blank style='color:#2F92EE;'>#饮酒量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101215, encryptionId=6d061012155a, topicName=饮酒量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2e0330, createdName=huangdf, createdTime=Sat May 21 12:40:00 CST 2016, time=2016-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1847702, encodeId=5e1a184e702d5, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Wed Apr 20 10:40:00 CST 2016, time=2016-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061476, encodeId=3b7520614e6f4, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sun Sep 06 09:40:00 CST 2015, time=2015-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35968, encodeId=59283596846, content=不错。, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1ab1619415, createdName=lecoo, createdTime=Sun Aug 23 00:20:00 CST 2015, time=2015-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413431, encodeId=2e6b14134317c, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sat Aug 22 10:40:00 CST 2015, time=2015-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601354, encodeId=e83316013540d, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Aug 22 10:40:00 CST 2015, time=2015-08-22, status=1, ipAttribution=)]
    2015-08-22 zhaojie88

相关资讯

Journal of Hepatology:哪种饮酒模式容易得肝硬化?

酒精是导致酒精性肝硬化最主要的病因,但较少人知道饮酒模式的意义,哪种饮酒模式更容易得肝硬化呢?来自丹麦的研究人员进行了这样一项有趣,同时又贴近生活的研究,该项研究成果发表在近期的Journal of Hepatology 方法 我们在丹麦从1993年到2011年期间关于肿瘤、饮食、健康研究中的55917例参与者(年龄50岁-64岁)中调查了酒精性肝硬化的危险因素。基线信息通过问卷获得,包括酒精

最坑爹饮酒有益的十四大谎言

红酒被很多人都认为养颜延缓衰老的佳品。其实,不管是什么酒,是有害或者有益关键还在于控制饮用量。最新一项大型科学研究显示:中年人饮酒引发中风的危害堪比高血压和糖尿病(见:Stroke:饮酒增加卒中风险堪比高血压、糖尿病 )。当然,也有研究显示,微量饮酒(注意:微量)可能真有益健康(见:BMJ:饮酒少者心血管系统更健康),但总体来说,还是弊大于利(见:饮酒对大脑影响利弊谈)。今天就让小编来给大家说

Breast Cancer Res Treat:饮酒并不会增加BRCA1和BRCA2突变基因携带者乳腺癌的风险

背景:一般人群中酒精对女性乳腺癌的发展是有不利影响的,我们评估在BRCA1或BRCA2基因突变的女性中的这种关联是否也类似的存在。方法:每日酒精消耗量的相关基线信息来自对前瞻性研究组招募的3067 BRCA突变携带者进行的调查问卷。每两年进行一次女性随访调查,直到最后随访问卷的日期,乳腺癌的诊断日期、侧乳预防性切除的日期或死亡日期。Cox比例风险模型用来评估相对风险(RRs),95%置信区间(CI

BMJ Open:怀孕期间女性是不是常好“喝两杯”?

本研究旨在对比多个队列研究中妊娠期女性酒精的饮用率及其预测因素。  研究共纳入了的17244名女性,主要为白人女性,来源于两个爱尔兰回顾性研究,(在爱尔兰长大(GUI)及爱尔兰怀孕风险评估监测系统(PRAMS爱尔兰))以及一个多中心前瞻性国际队列研究,妊娠终点筛查(SCOPE)研究。收集研究对象怀孕前及怀孕期间酒精的饮用率以及与酒精消耗相关的社会人口因素数据。结果发现,SCOPE研究中爱

BMJ Open:成功高龄人士更易出现有害饮酒

英国老年人研究协会的José Iparraguirre教授表示,饮酒可能是一个“隐藏的健康和社会问题的成功者之一”,即饮酒为人们带来健康和社会问题又不被人重视。Iparraguirre教授认为,对这些人进行酒精的消费指导是非常有必要的。据美国国家酒精滥用和中毒研究所的研究显示,美国大约有1.66千万名成年人因为饮酒导致相关疾病的发生。每年有超过88000美国人死于酒精相关性疾病。饮酒是导致美国民众

美国癌症协会:预防癌症的九点建议

美国癌症协会:预防癌症的五大建议每天我们都可以在医学网站和书刊上看到这样的报道:“某某食物可以预防癌症、某某饮食方式可以让你远离癌症。”然而,作为医学工作者和科研人员的我们禁不住要质疑这些传言到底有没有科学依据?来自英国南曼彻斯特大学的 Michelle Harvie 教授在 2015 ASCO 年会上指出,当前预防癌症的建议大多来自观察性研究,而非随机试验的结果。因此我们很难验证观察性研究中两因